Literature DB >> 6628005

Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma.

G R Owens, G J Fino, D L Herbert, V D Steen, T A Medsger, B E Pennock, J J Cottrell, G P Rodnan, R M Rogers.   

Abstract

The pulmonary function and chest roentgenograms were evaluated in 88 patients with the CREST syndrome variant of progressive systemic sclerosis (PSS or scleroderma). Seventy-two percent of the patients had abnormal pulmonary function. An isolated decrease in diffusing capacity was the most common abnormality noted, followed by restrictive abnormalities and airway obstruction. Chest roentgenograms revealed interstitial infiltrates consistent with pulmonary fibrosis in 33 percent. When compared to a contemporaneous group of 77 patients with PSS and diffuse scleroderma, patients with the CREST syndrome had similar abnormalities on pulmonary function testing and chest roentgenogram. However, patients with the CREST syndrome had a lower mean diffusing capacity despite a higher mean vital capacity; this combination of findings suggests primary pulmonary vascular disease. Calcified granulomata were identified significantly more often in PSS-CREST patients, while superior rib notching occurred exclusively in patients with PSS and diffuse scleroderma. The CREST variant of PSS is associated with frequent roentgenographic and pulmonary function abnormalities similar to those seen in PSS with diffuse scleroderma.

Entities:  

Mesh:

Year:  1983        PMID: 6628005     DOI: 10.1378/chest.84.5.546

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  High resolution computed tomography as a predictor of lung histology in systemic sclerosis.

Authors:  A U Wells; D M Hansell; B Corrin; N K Harrison; P Goldstraw; C M Black; R M du Bois
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

2.  Rheumatoid arthritis in Greece. Manifestations in different age groups.

Authors:  A P Andonopoulos; V Galanopoulou; A A Drosos; H M Moutsopoulos
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

3.  A longitudinal study of pulmonary function in Danish patients with systemic sclerosis.

Authors:  S Jacobsen; P Halberg; S Ullman; M Høier-Madsen; J Petersen; J Mortensen; A Wiik
Journal:  Clin Rheumatol       Date:  1997-06       Impact factor: 2.980

4.  Pulmonary function of nonsmoking patients with giant cell arteritis and/or polymyalgia rheumatica; a controlled study.

Authors:  N C Acritidis; A P Andonopoulos; V Galanopoulou; A A Drosos; S H Constantopoulos
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

5.  CREST syndrome with pericardial but not peripheral calcinosis.

Authors:  H G Taylor; P Sheldon; A J McCance; J D Skehan
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

6.  Treatment of pulmonary hypertension in patients with connective tissue disease and interstitial lung disease.

Authors:  Shikha Mittoo; Thomas Jacob; Andrea Craig; Zoheir Bshouty
Journal:  Can Respir J       Date:  2010 Nov-Dec       Impact factor: 2.409

7.  T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.

Authors:  Francesco Boin; Umberto De Fanis; Susan J Bartlett; Fredrick M Wigley; Antony Rosen; Vincenzo Casolaro
Journal:  Arthritis Rheum       Date:  2008-04

Review 8.  Scleroderma lung: pathogenesis, evaluation and current therapy.

Authors:  Jacob M van Laar; Jan Stolk; Alan Tyndall
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Early pulmonary disease in systemic sclerosis: a comparison between carbon monoxide transfer factor and static lung compliance.

Authors:  A Scheja; A Akesson; P Wollmer; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

10.  Scleroderma lung disease.

Authors:  Jérôme Le Pavec; David Launay; Stephen C Mathai; Paul M Hassoun; Marc Humbert
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.